30 years of Synthetic Insulin
Are people with diabetes getting the best deal?
This report looks at the lessons that can be learned from the 30 years since the introduction of synthetic insulins and questions the influence of the pharmaceutical industry on patients’ choice of insulin treatment. It looks forward to developing ways of protecting the best interests of people with diabetes who need and deserve treatment that is based on evidence of benefit while at the same time, being cost effective.
30 years of Synthetic Insulin – English version
30 years of Synthetic Insulin – German version